NCT06603298View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Endoscopic Dilatation and Biological Therapy in Intestinal Stenosis Due to CD

Active, not recruitingOBSERVATIONAL

Enrollment

182

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

October 17, 2025

Study Completion Date

October 17, 2025

Conditions

Crohn Disease

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC CEMAD, Roma

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06603298 - Evaluation of the Efficacy and Safety of Endoscopic Dilatation and Biological Therapy in Intestinal Stenosis Due to CD | Biotech Hunter | Biotech Hunter